Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter BCL6 Antikörper (AA 256-389)

Dieses Anti-BCL6-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von BCL6 in IHC (f). Geeignet für Human.
Produktnummer ABIN6936496

Kurzübersicht für Rekombinanter BCL6 Antikörper (AA 256-389) (ABIN6936496)

Target

Alle BCL6 Antikörper anzeigen
BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 159
  • 61
  • 25
  • 9
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 92
  • 65
  • 2
  • 1
Maus

Klonalität

  • 98
  • 62
Monoklonal

Konjugat

  • 79
  • 13
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Dieser BCL6 Antikörper ist unkonjugiert

Applikation

  • 71
  • 69
  • 40
  • 38
  • 32
  • 26
  • 18
  • 13
  • 10
  • 8
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

RBCL6-1718
  • Bindungsspezifität

    • 60
    • 11
    • 11
    • 7
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 256-389

    Spezifität

    Recognizes a protein of 95kDa, which is identified as Bcl-6. Antibody to bcl-6 is helpful in a number of diagnostic settings: (1) In the differential diagnosis of small B-cell lymphoma. Follicular lymphoma will show bcl-6 (and CD10) positivity whereas other small B-cell lymphomas are usually negative. (2) Bcl-6 is an important prognostic marker in diffuse large B-cell lymphomas (DLBCL), where CD10, bcl-6 and MUM1/IRF4 are used to identify germinal center and activated B-cell phenotypes. (3) Bcl-6 can be valuable in distinguishing classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). The Reed-Sternberg cells of classical Hodgkin lymphoma are bcl-6 negative whereas the large ('LH') cells of NLPHL are bcl-6 positive. In contrast, anti-Bcl-6 rarely stains mantle-cell lymphoma and MALT lymphoma.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human bcl-6 protein fragment (aa256-389) (exact sequence is proprietary)

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: Raji or Ramos cells. Tonsil or Hodgkin's lymphoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    BCL6 (B-Cell CLL/lymphoma 6 (BCL6))

    Andere Bezeichnung

    BCL6

    Hintergrund

    B-cell lymphoma 5 protein, B-Cell Lymphoma 6 Protein, BCL5, BCL6, BCL6A, cys his2 zinc finger transcription factor, Lymphoma Associated Zinc Finger Gene On Chromosome 3 (LAZ3), Zinc finger and BTB domain-containing protein 27 (ZBTB27), Zinc Finger Protein 51 (ZNF51), zinc finger transcription factor BCL6S,Bcl-6 (Follicular Lymphoma Marker)
    Cellular localisation: Nuclear

    Molekulargewicht

    95kDa

    Gen-ID

    604, 478588

    UniProt

    P41182

    Pathways

    Chromatin Binding, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Protein targeting to Nucleus
Sie sind hier:
Chat with us!